Within his role as a Managing Director at ClearView Healthcare Partners, Mike assists clients in developing product and therapeutic area strategies and provides a unique perspective on global pricing, reimbursement, and market access. In addition to broad therapeutic area knowledge, Mike has expertise in characterizing the roles and impact of organized customers, including regulators, payers, distributors, hospital systems, and provider groups. He places significant importance on professional mentorship, client focus, and developing practical solutions for complex business needs.
Mike began his life-sciences career in genomics research before transitioning into healthcare policy and finally establishing himself in consulting. Over the last 10 years he has focused on addressing strategic business issues for leading pharmaceutical and biotechnology companies. Prior to joining ClearView, Mike held positions at Leerink Swann, Double Helix and Campbell Alliance.
Mike holds an MBA from the College of William and Mary and a Master of Public Policy focused on pharmaceutical pricing regulations from Georgetown University.